Drug Database
Back to search

Belgium· BE-AMP-SAM193462-00

Acebutolol Teva 400 mg

A acebutolol product containing acebutolol hydrochloride, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 10 of our 19 countries.

ATC C07AB04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAcebutolol Teva 400 mgATCC07AB04REGISTER NO.BE-AMP-SAM193462-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acebutolol hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acebutolol is registered in 10 of 19 countries.

Countries holding a registration under ATC C07AB04 (acebutolol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search acebutolol products by name

Acebutolol · ATC C07AB04

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acebutolol costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acebutolol · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • FR France$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Acebutolol Hydrochloride
Manufacturer
Teva Pharma Belgium
Country
Belgium (BE)
ATC code
C07AB04
ATC class
Acebutolol
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    1434489
  • be_apb
    0760587

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

295 interactions on record for acebutolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acebutolol against other medicinesHow interaction checks work

Acebutolol · interactions on record

295 records

  • 11 severe
  • 184 moderate
  • 21 minor
  • 79 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acebutolol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acebutolol products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Czechia · Acecor, Sectral
  • France · Acebutolol Almus, Acebutolol Arrow Lab
  • United Kingdom (Northern Ireland) · Acebutolol Milpharm, Sectral
  • Italy · Sectral
  • Netherlands · Acebutolol Hydrochloride Aurobindo
  • Poland · Acebutolol Gedeon Richter, Acecor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/62b5e18b-710d-4bc4-a6a2-0e7e93b33f73
GET /v1/drugs/62b5e18b-710d-4bc4-a6a2-0e7e93b33f73?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Acebutolol Teva 400 mg",
  "name_fr": "Acebutolol Teva 400 mg",
  "name_nl": "Acebutolol Teva 400 mg",
  "amp_code": "SAM193462-00",
  "strengths": [
    "443.4000",
    "400.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Acebutolol Hydrochloride",
    "Acebutolol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Acebutolol",
  "authorisation_numbers": [
    "BE193462"
  ]
}
API referenceMCP serverPlans

See everything about acebutolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console